Trial Profile
Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2018
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Obsessive-compulsive disorders
- Focus Adverse reactions; Therapeutic Use
- 25 May 2018 Status changed from recruiting to completed.
- 26 Nov 2005 New trial record.